1H MR spectroscopy in common dementias

被引:37
作者
Kantarci, K
Petersen, RC
Boeve, BF
Knopman, DS
Tang-Wai, DF
O'Brien, PC
Weigand, SD
Edland, SD
Smith, GE
Ivnik, RJ
Ferman, TJ
Tangalos, EG
Jack, CR
机构
[1] Mayo Clin & Mayo Fdn, Dept Diagnost Radiol, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Neurol, Rochester, MN 55905 USA
[3] Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA
[4] Mayo Clin & Mayo Fdn, Dept Clin Epidemiol, Rochester, MN 55905 USA
[5] Mayo Clin & Mayo Fdn, Dept Psychiat & Psychol, Rochester, MN 55905 USA
[6] Mayo Clin & Mayo Fdn, Dept Internal Med, Rochester, MN 55905 USA
[7] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA
[8] Mayo Clin, Dept Psychiat & Psychol, Jacksonville, FL 32224 USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To determine the H-1 MR spectroscopic (MRS) findings and intergroup differences among common dementias: Alzheimer disease ( AD), vascular dementia (VaD), dementia with Lewy bodies (DLB), and frontotemporal lobar degeneration (FTLD). Methods: The authors consecutively recruited 206 normal elderly subjects and 121 patients with AD, 41 with FTLD, 20 with DLB, and 8 with VaD. The 1H MRS metabolite ratio changes in common dementias were evaluated with respect to normal and also differences among the common dementias. Results: N-Acetylaspartate (NAA)/creatine (Cr) was lower than normal in patients with AD, FTLD, and VaD. Myo-inositol (mI)/Cr was higher than normal in patients with AD and FTLD. Choline (Cho)/Cr was higher than normal in patients with AD, FTLD, and DLB. There were no metabolite differences between patients with AD and FTLD or between patients with DLB and VaD. NAA/Cr was lower in patients with AD and FTLD than DLB. MI/Cr was higher in patients with AD and FTLD than VaD. MI/Cr was also higher in patients with FTLD than DLB. Conclusions: NAA/Cr levels are decreased in dementias that are characterized by neuron loss, such as AD, FTLD, and VaD. MI/Cr levels are elevated in dementias that are pathologically characterized by gliosis, such as AD and FTLD. Cho/Cr levels are elevated in dementias that are characterized by a profound cholinergic deficit, such as AD and DLB.
引用
收藏
页码:1393 / 1398
页数:6
相关论文
共 38 条
[1]
[Anonymous], 1987, DIAGNOSTIC STAT MANU, V4th
[2]
Bitsch A, 1999, AM J NEURORADIOL, V20, P1619
[3]
Metabolic and cognitive response to human traumatic brain injury: A quantitative proton magnetic resonance study [J].
Brooks, WM ;
Stidley, CA ;
Petropoulos, H ;
Jung, RE ;
Weers, DC ;
Friedman, SD ;
Barlow, MA ;
Sibbitt, WL ;
Yeo, RA .
JOURNAL OF NEUROTRAUMA, 2000, 17 (08) :629-640
[4]
Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry [J].
Burton, EJ ;
Karas, G ;
Paling, SM ;
Barber, R ;
Williams, ED ;
Ballard, CG ;
McKeith, IG ;
Scheltens, P ;
Barkhof, F ;
O'Brien, JT .
NEUROIMAGE, 2002, 17 (02) :618-630
[5]
Assessment of 3D proton MR echo-planar spectroscopic imaging using automated spectral analysis [J].
Ebel, A ;
Soher, BJ ;
Maudsley, AA .
MAGNETIC RESONANCE IN MEDICINE, 2001, 46 (06) :1072-1078
[6]
Frontotemporal dementia and early Alzheimer disease: Differentiation with frontal lobe H-1 NTR spectroscopy [J].
Ernst, T ;
Chang, L ;
Melchor, R ;
Mehringer, CM .
RADIOLOGY, 1997, 203 (03) :829-836
[7]
DIFFERENCES IN THE METABOLISM OF INOSITOL AND PHOSPHOINOSITIDES BY CULTURED-CELLS OF NEURONAL AND GLIAL ORIGIN [J].
GLANVILLE, NT ;
BYERS, DM ;
COOK, HW ;
SPENCE, MW ;
PALMER, FBSC .
BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 1004 (02) :169-179
[8]
Clinicopathologic correlates in temporal cortex in dementia with Lewy bodies [J].
Gómez-Isla, T ;
Growdon, WB ;
McNamara, M ;
Newell, K ;
Gómez-Tortosa, E ;
Hedley-Whyte, ET ;
Hyman, BT .
NEUROLOGY, 1999, 53 (09) :2003-2009
[9]
Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies [J].
Holmes, C ;
Cairns, N ;
Lantos, P ;
Mann, A .
BRITISH JOURNAL OF PSYCHIATRY, 1999, 174 :45-50
[10]
Brain metabolite concentration and dementia severity in Alzheimer's disease -: A 1H MRS study [J].
Huang, W ;
Alexander, GE ;
Chang, L ;
Shetty, HU ;
Krasuski, JS ;
Rapoport, SI ;
Schapiro, MB .
NEUROLOGY, 2001, 57 (04) :626-632